LLY
UNDERPERFORMEli Lilly and Company · Healthcare
$939.80-1.61%LAST CLOSE
24H-1.61%
1W+0.45%
1M-6.00%
1Y+30.36%
Live Chart · LLY
1DNY TIME
BOGA Master Score
37.8
High conviction score
BOGA AI Model Projection
Strategic Observation Zone$935.10 - $944.50
Projected Growth Objective$1,004.71 - $1,076.47
Model Invalidation Level$838.72 - $882.86
Risk/Reward1.5:1
AD-S2 · 300×250 Sidebar
Technical Indicators
RSI (14)
47.7
Neutral
MACD
7.877
NEUTRAL
RVOL
0.66x
Normal
Trends
UP
UP
EMA Stack
Bearish
STABLE
BB Squeeze
LOW
MONITOR
Fundamentals & Margins
Market Cap
P/E Ratio
vs Sector: 25.0730915
FCF Yield
Gross Margin
Operating Margin
Net Margin
Sector Context
Benchmarked against
XLV
5D Performance
+1.3%
LLY is currently ranked in the top 20% of its sector based on BOGA Master Scores. It has outperformed XLV by 4.2% over the last 30 trading days.
Insider Activity (90D)
| Transaction | Shares | Net Direction |
|---|---|---|
| Buys | 0 | NEUTRAL |
| Sells | 0 |
Last Transaction: SELL 5 shares

Share This Insight
Help others discover this score. Professional analysts share high-conviction data.
Share This Insight
Help others discover this score. Professional analysts share high-conviction data.